Search research articles
Contact Us
Filters
Showing results (291-300 of 329) with videos related to
Page
of 33
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 28, 2021
The radiotherapy quality assurance gap among phase III cancer clinical trials
Kelsey L Corrigan, Stephen Kry, Rebecca M Howell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2020
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma
Martin Voss, Marlies Wagner, Nina von Mettenheim, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 9, 2024
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology
Simone Wegen, Ursula Nestle, Constantinos Zamboglou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Alexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
International Journal of Cancer
|
March 15, 2019
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial
Markus Diefenhardt, Ralf-Dieter Hofheinz, Daniel Martin, et al.
Cancer Research
|
February 2, 2022
Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma Growth but Promotes Metastasis
Eiman Elwakeel, Mirko Brüggemann, Jessica Wagih, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials
Emmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
The Lancet. Gastroenterology & Hepatology
|
May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
Cihan Gani, Emmanouil Fokas, Bülent Polat, et al.
Clinical and Translational Radiation Oncology
|
May 19, 2020
RADIANCE - Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
Daniel Martin, Panagiotis Balermpas, Johannes Gollrad, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 4, 2026
A composite measure of cerebral small vessel disease predicts cognitive change after stroke
Mahir H Khan, Stuti Chakraborty, Octavio Marin-Pardo, et al.
Page
of 33
Search research articles
Search
Showing results (291-300 of 329) with videos related to
Sort By:
Page
of 33
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 28, 2021
The radiotherapy quality assurance gap among phase III cancer clinical trials
Kelsey L Corrigan, Stephen Kry, Rebecca M Howell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2020
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma
Martin Voss, Marlies Wagner, Nina von Mettenheim, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 9, 2024
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology
Simone Wegen, Ursula Nestle, Constantinos Zamboglou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Alexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
International Journal of Cancer
|
March 15, 2019
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial
Markus Diefenhardt, Ralf-Dieter Hofheinz, Daniel Martin, et al.
Cancer Research
|
February 2, 2022
Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma Growth but Promotes Metastasis
Eiman Elwakeel, Mirko Brüggemann, Jessica Wagih, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials
Emmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
The Lancet. Gastroenterology & Hepatology
|
May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
Cihan Gani, Emmanouil Fokas, Bülent Polat, et al.
Clinical and Translational Radiation Oncology
|
May 19, 2020
RADIANCE - Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
Daniel Martin, Panagiotis Balermpas, Johannes Gollrad, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 4, 2026
A composite measure of cerebral small vessel disease predicts cognitive change after stroke
Mahir H Khan, Stuti Chakraborty, Octavio Marin-Pardo, et al.
Page
of 33